Azerbaijan vs South-East Asia (WHO region): HIV-positive TB patients on ART (antiretroviral therapy)

Azerbaijan
100.0%
in 2024
South-East Asia (WHO region)
94.0%
in 2024
Azerbaijan rank
1st
South-East Asia (WHO region) rank
4th

HIV-positive TB patients on ART (antiretroviral therapy) over time

  • Azerbaijan
  • South-East Asia (WHO region)
020406080100200320132024

How they compare

Azerbaijan currently reports 100.0% against 94.0% in South-East Asia (WHO region), a difference of 6.0%.

That makes Azerbaijan's figure about 1.1 times South-East Asia (WHO region)'s.

The two have swapped places 4 times across 14 shared years of data; in 2011 it was Azerbaijan ahead.

Azerbaijan ranks 1st and South-East Asia (WHO region) ranks 4th of 144 countries.

Across the 2 decades both report, Azerbaijan averaged higher in 1 and South-East Asia (WHO region) in 1.

Head to head by decade

Decade Azerbaijan South-East Asia (WHO region) Difference Ahead
2010s 73.8% 78.1% 4.3% South-East Asia (WHO region)
2020s 98.2% 92.2% 6.0% Azerbaijan

Averages of every year both report within each decade.

Frequently asked questions

Which has higher hiv-positive tb patients on art (antiretroviral therapy), Azerbaijan or South-East Asia (WHO region)?
Azerbaijan, at 100.0% against 94.0% in South-East Asia (WHO region) as of 2024.
What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Azerbaijan and South-East Asia (WHO region)?
6.0%, with Azerbaijan ahead.
How many years of comparable data are there for Azerbaijan and South-East Asia (WHO region)?
14 years are reported by both, from 2011 to 2024.
How do Azerbaijan and South-East Asia (WHO region) rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
Azerbaijan ranks 1st and South-East Asia (WHO region) ranks 4th of 144 countries.
Where does this data come from?
World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Azerbaijan vs South-East Asia (WHO region): HIV-positive TB patients on ART (antiretroviral therapy). Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 18 September 2026, from https://health.statizoid.com/compare/hiv-positive-tb-patients-on-art-antiretroviral-therapy-percent/azerbaijan/south-east-asia-who-region/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/compare/hiv-positive-tb-patients-on-art-antiretroviral-therapy-percent/azerbaijan/south-east-asia-who-region/">Azerbaijan vs South-East Asia (WHO region): HIV-positive TB patients on ART (antiretroviral therapy)</a> — Statizoid

About this data

Indicator
HIV-positive TB patients on ART (antiretroviral therapy) (%)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
157 places, 2,569 data points, 2003–2024
Last refreshed